Molecularly targeted drugs for metastatic colorectal cancer
Ying-dong Cheng, Hua Yang, Guo-qing Chen, Zhi-cao Zhang Department of General Surgery, Xinqiao Hospital, Third Military Medical University, Chongqing, People's Republic of China Abstract: The survival rate of patients with metastatic colorectal cancer (mCRC) has significantly improved with...
Main Authors: | Cheng YD, Yang H, Chen GQ, Zhang ZC |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-11-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/molecularly-targeted-drugs-for-metastatic-colorectal-cancer-peer-reviewed-article-DDDT |
Similar Items
-
Molecular Targets for the Treatment of Metastatic Colorectal Cancer
by: Romain Cohen, et al.
Published: (2020-08-01) -
Oral drugs in the treatment of metastatic colorectal cancer
by: Pilar García-Alfonso, et al.
Published: (2021-04-01) -
Target Therapy in Unresectable or Metastatic Colorectal Cancer
by: Jae Hyun Kim, et al.
Published: (2016-12-01) -
Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer
by: Peter W. Eide, et al.
Published: (2021-07-01) -
Targeting Metastatic Colorectal Cancer with Immune Oncological Therapies
by: Norman J. Galbraith, et al.
Published: (2021-07-01)